NCT03354897View on ClinicalTrials.gov

Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
Cardiovascular DiseasesHypertension
Interventions
DRUG

Torasemide 5Mg Tablet

16 weeks treatment

Trial Locations (1)

G51 4TF

Glasgow Clinical Research Facility, Glasgow

All Listed Sponsors
collaborator

University of Glasgow

OTHER

collaborator

British Heart Foundation

OTHER

lead

NHS Greater Glasgow and Clyde

OTHER

NCT03354897 - Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension | Biotech Hunter | Biotech Hunter